InspireMD (NSPR) Revenue & Revenue Breakdown


OverviewForecastFinancialsChartTranscripts

InspireMD Revenue Highlights


Latest Revenue (Y)

$7.01M

Latest Revenue (Q)

$1.74M

Main Segment (Y)

CGuard EPS

Main Geography (Y)

Other Countries

InspireMD Revenue by Period


InspireMD Revenue by Year

DateRevenueChange
2024-12-31$7.01M12.96%
2023-12-31$6.21M20.00%
2022-12-31$5.17M15.04%
2021-12-31$4.50M80.89%
2020-12-31$2.48M-33.22%
2019-12-31$3.72M3.33%
2018-12-31$3.60M30.42%
2017-12-31$2.76M45.78%
2016-12-31$1.89M-18.01%
2015-12-31$2.31M-18.03%
2014-12-31$2.82M-42.17%
2013-06-30$4.87M-8.90%
2012-06-30$5.35M-10.91%
2011-12-31$6.00M100.00%
2010-06-30-100.00%
2009-06-30--

InspireMD generated $7.01M in revenue during NA 2024, up 12.96% compared to the previous quarter, and up 188.36% compared to the same period a year ago.

InspireMD Revenue by Quarter

DateRevenueChange
2024-06-30$1.74M15.09%
2024-03-31$1.51M-14.20%
2023-12-31$1.76M13.17%
2023-09-30$1.56M-5.64%
2023-06-30$1.65M33.09%
2023-03-31$1.24M20.76%
2022-12-31$1.03M-28.30%
2022-09-30$1.43M-6.53%
2022-06-30$1.53M29.42%
2022-03-31$1.18M-14.28%
2021-12-31$1.38M28.85%
2021-09-30$1.07M3.18%
2021-06-30$1.04M3.18%
2021-03-31$1.01M536.71%
2020-12-31$158.00K-83.88%
2020-09-30$980.00K213.10%
2020-06-30$313.00K-69.73%
2020-03-31$1.03M2.07%
2019-12-31$1.01M7.88%
2019-09-30$939.00K-30.65%
2019-06-30$1.35M226.27%
2019-03-31$415.00K-49.51%
2018-12-31$822.00K6.89%
2018-09-30$769.00K-23.33%
2018-06-30$1.00M-0.40%
2018-03-31$1.01M20.89%
2017-12-31$833.00K16.02%
2017-09-30$718.00K12.19%
2017-06-30$640.00K12.48%
2017-03-31$569.00K76.71%
2016-12-31$322.00K-31.34%
2016-09-30$469.00K-13.15%
2016-06-30$540.00K-4.09%
2016-03-31$563.00K9.11%
2015-12-31$516.00K-18.35%
2015-09-30$632.00K-7.74%
2015-06-30$685.00K43.61%
2015-03-31$477.00K-45.17%
2014-12-31$870.00K218.68%
2014-09-30$273.00K41.45%
2014-06-30$193.00K-86.98%
2014-03-31$1.48M-4.51%
2013-09-30$1.55M3.47%
2013-06-30$1.50M-0.92%
2013-03-31$1.51M12.15%
2012-12-31$1.35M165.23%
2012-09-30$509.00K-45.27%
2012-06-30$930.00K-18.28%
2012-03-31$1.14M-11.92%
2011-12-31$1.29M-34.94%
2011-09-30$1.99M90.96%
2011-06-30$1.04M-38.32%
2011-03-31$1.69M100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--

InspireMD generated $1.74M in revenue during Q2 2024, up 15.09% compared to the previous quarter, and up 140.36% compared to the same period a year ago.

InspireMD Revenue Breakdown


InspireMD Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
CGuard EPS$5.12M
MGuard Prime EPS$48.00K

InspireMD's latest annual revenue breakdown by segment (product or service), as of Dec 22: CGuard EPS (99.07%), and MGuard Prime EPS (0.93%).

Quarterly Revenue by Product

Product/ServiceSep 23Sep 22
CGuard EPS$1.56M-
CGuard-$1.43M

InspireMD's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: CGuard EPS (100.00%).

InspireMD Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
ITALY$1.22M
GERMANY$926.00K
Other Countries$4.15M

InspireMD's latest annual revenue breakdown by geography, as of Dec 24: Other Countries (65.87%), ITALY (19.43%), and GERMANY (14.71%).

Quarterly Revenue by Country

CountryDec 24Sep 24Jun 24Mar 24
Other Countries$1.53M$832.00K$961.00K$822.00K
GERMANY$71.00K$306.00K$307.00K$242.00K
ITALY$358.00K$306.00K$264.00K$295.00K
POLAND-$176.00K$207.00K$152.00K

InspireMD's latest quarterly revenue breakdown by geography, as of Dec 24: Other Countries (78.12%), ITALY (18.26%), and GERMANY (3.62%).

InspireMD Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SRDXSurmodics$126.08M$29.92M
NPCENeuroPace$79.91M$21.06M
SGHTSight Sciences$79.87M$20.16M
LNSRLENSAR$53.49M$13.54M
IRIXIRIDEX$48.67M$11.58M
SSKNSTRATA Skin Sciences$33.56M$8.44M
RPIDRapid Micro Biosystems$28.05M$7.60M
VVOSVivos Therapeutics$15.03M$3.86M
NUWENuwellis$8.74M$2.37M
RSLSReShape Lifesciences$8.68M$2.29M
NSPRInspireMD$7.01M$1.74M
TNONTenon Medical$3.28M$887.00K
TIVCTivic Health Systems$780.00K$126.00K
BBLGBone Biologics--
AIMDAinos--
BJDXBluejay Diagnostics--

NSPR Revenue FAQ


What is InspireMD’s yearly revenue?

InspireMD's yearly revenue for 2024 was $7.01M, representing an increase of 12.96% compared to 2023. The company's yearly revenue for 2023 was $6.2M, representing an increase of 20.00% compared to 2022. NSPR's yearly revenue for 2022 was $5.17M, representing an increase of 15.04% compared to 2021.

What is InspireMD’s quarterly revenue?

InspireMD's quarterly revenue for Q2 2024 was $1.74M, a 15.09% increase from the previous quarter (Q1 2024), and a 5.46% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.51M, a -14.20% decrease from the previous quarter (Q4 2023), and a 21.95% increase year-over-year (Q1 2023). NSPR's quarterly revenue for Q4 2023 was $1.76M, a 13.17% increase from the previous quarter (Q3 2023), and a 71.64% increase year-over-year (Q4 2022).

What is InspireMD’s revenue growth rate?

InspireMD's revenue growth rate for the last 3 years (2022-2024) was 35.54%, and for the last 5 years (2020-2024) was 182.05%.

What are InspireMD’s revenue streams?

InspireMD's revenue streams in c 22 are CGuard EPS, and MGuard Prime EPS. CGuard EPS generated $5.12M in revenue, accounting 99.07% of the company's total revenue MGuard Prime EPS generated $48K in revenue, accounting 0.93% of the company's total revenue

What is InspireMD’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of InspireMD was CGuard EPS. This segment made a revenue of $5.12M, representing 99.07% of the company's total revenue.